Parkinson’s Disease: Understanding the Root Causes Beyond Dopamine

Author: Dr. Jamie Ahn, ND

At a Glance

1. Parkinson’s motor symptoms (tremor, rigidity, slowed movement) come from the loss of dopamine-producing neurons, but that loss may be the end stage of a process that starts years earlier, often in the gut.
2. A functional medicine approach doesn’t replace dopamine therapy. It investigates what may be driving ongoing neuron loss: toxin exposure, mitochondrial dysfunction, and gut-driven inflammation.
3. This page covers the research behind that model, what we test for, what our treatment approach involves, and honestly, what the evidence does and doesn’t support.

What’s Happening in the Brain, and Where It May Start

Parkinson’s disease is conventionally defined by the progressive loss of dopamine-producing neurons in the substantia nigra, a region deep in the midbrain. As dopamine levels fall, the classic motor symptoms appear: resting tremor, muscle rigidity, bradykinesia, and balance problems.

But there’s evidence the biological story starts earlier than that. The Braak staging model, first proposed in the early 2000s and refined since, suggests that in many cases the underlying pathology begins in the enteric nervous system (the gut’s own nervous system) and the olfactory bulb, with misfolded alpha-synuclein protein migrating into the brain over time via the vagus nerve.

This is one proposed explanation, not a settled fact, for why symptoms like chronic constipation, loss of smell, REM sleep disturbances, and new-onset anxiety often show up years before any motor symptoms do. Not every Parkinson’s case follows this pattern, and researchers are still working out how consistently it applies.

Factors researchers have implicated in that earlier-stage process include:

1. Long-term exposure to certain agricultural chemicals (rotenone and paraquat are the most studied)
2. Accumulated exposure to heavy metals such as manganese and lead
3. Impaired mitochondrial energy production inside dopamine-producing neurons
4. Ongoing low-grade inflammation in the brain’s immune cells (microglia)

Why Dopamine Medication Isn’t the Whole Picture

Levodopa and other dopamine-replacement therapies are genuinely effective and can meaningfully improve quality of life. They are also not designed to address whatever is causing dopamine-producing neurons to keep dying. That’s a limitation of what they’re for, not a flaw in the medication.

Over time, many patients need higher or more frequent doses, and some develop side effects like dyskinesia or unpredictable “off” periods. A functional medicine approach is meant to sit alongside standard neurological care, not instead of it: it asks what else might be contributing to disease progression, ongoing inflammation, toxin exposure, or gut health, and whether addressing those things can support the nervous system over time.

We take the same root-cause approach in our related work on mycotoxin exposure and neurological symptoms and on unexplained neurological symptoms more broadly.

How We Evaluate Parkinson’s in Our Norwalk, CT Practice

No two patients arrive with the same combination of toxin exposures, gut health, or nutrient status, so we build each plan around individual testing rather than a fixed protocol. Depending on your history and symptoms, that may include:

1. Organic acid testing (urine) assesses metabolic markers related to mitochondrial function and dopamine metabolism.
2. Toxic metal testing checks exposure to manganese, mercury, lead, and cadmium.
3. Gut microbiome/stool analysis: looks for bacterial imbalances associated with intestinal permeability and gut-driven inflammation.
4. Environmental toxicant testing: screens for pesticide and industrial solvent exposure.
5. Nutrient and antioxidant status: including glutathione, which several studies have identified as depleted early in Parkinson’s disease progression (see Sources).

What Our Treatment Approach Involves

Once we have a clearer picture of your individual contributing factors, a plan may include:

1. An anti-inflammatory, lower-glycemic dietary approach
2. Support for clearing heavy metals or pesticide residue, where testing indicates exposure
3. Gut microbiome support aimed at reducing gut-driven inflammation
4. Targeted nutrient support (such as CoQ10, NAC, or glutathione) aims to support mitochondrial function and antioxidant capacity.

In our practice, most patients come to us already on levodopa or another prescribed therapy and are looking for ways to support their overall resilience alongside it. This approach is designed to complement that care, in coordination with your neurologist.

What This Approach Can and Cannot Do

We think it’s important to be direct about this:

Functional and naturopathic approaches to Parkinson’s are an active, evolving area, and they are not a proven way to reverse or cure the disease, and they should not replace neurologist-directed care. The research on gut-brain involvement, environmental toxins, and mitochondrial dysfunction in Parkinson’s is real and growing, but the evidence that specific supplements or detoxification protocols slow disease progression in humans is still limited and, in many cases, preliminary. Our goal is to use testing to individualize supportive care and reduce unnecessary exposures and deficiencies — not to promise a specific outcome. We’ll always tell you where the evidence is strong, where it’s suggestive, and where it’s still uncertain.

Goodnews Naturopathic Clinic works with patients with different conditions throughout Fairfield County, CT, and the greater NYC metro area, both in person and by telehealth for established patients in eligible states.